Scholar Rock Holding (SRRK) Share-based Compensation (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.06% |
| Dec 31, 2025 | 5.96% |
| Sep 30, 2025 | -24.97% |
| Jun 30, 2025 | 82.16% |
| Mar 31, 2025 | 41.16% |
| Dec 31, 2024 | -1.53% |
| Sep 30, 2024 | 3.64% |
| Jun 30, 2024 | 14.05% |
| Mar 31, 2024 | 17.45% |
| Dec 31, 2023 | -3.50% |
| Sep 30, 2023 | 5.65% |
| Jun 30, 2023 | 10.50% |
| Mar 31, 2023 | 0.08% |
| Dec 31, 2022 | -22.13% |
| Sep 30, 2022 | 16.58% |
| Jun 30, 2022 | -0.54% |
| Mar 31, 2022 | 12.01% |
| Dec 31, 2021 | -0.94% |
| Sep 30, 2021 | -1.16% |
| Jun 30, 2021 | 33.23% |
| Mar 31, 2021 | 84.70% |
| Dec 31, 2020 | -37.31% |
| Sep 30, 2020 | 68.52% |
| Jun 30, 2020 | 8.18% |
| Mar 31, 2020 | 19.55% |
| Dec 31, 2019 | -31.10% |
| Sep 30, 2019 | 48.18% |
| Jun 30, 2019 | 12.11% |
| Mar 31, 2019 | -24.88% |
| Dec 31, 2018 | 44.95% |
| Sep 30, 2018 | 36.33% |
| Jun 30, 2018 | 126.14% |
| Mar 31, 2018 | -39.22% |
| Dec 31, 2017 | 294.53% |
| Sep 30, 2017 | -13.36% |